Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study

A quadrivalent, inactivated, split-virion influenza vaccine containing a strain from both B lineages (IIV4) has been developed, but its safety and immunogenicity in young children has not been described. This was a phase III, randomized, double-blind, active-controlled, multi-center study to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepin, Stephanie, Szymanski, Henryk, Rochín Kobashi, Ilya Angélica, Villagomez Martinez, Sandra, González Zamora, José Francisco, Brzostek, Jerzy, Huang, Li-Min, Chiu, Cheng-Hsun, Chen, Po-Yen, Ahonen, Anitta, Forstén, Aino, Seppä, Ilkka, Quiroz, René Farfán, Korhonen, Tiina, Rivas, Enrique, Monfredo, Celine, Hutagalung, Yanee, Menezes, Josemund, Vesikari, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215516/
https://www.ncbi.nlm.nih.gov/pubmed/27565435
http://dx.doi.org/10.1080/21645515.2016.1212143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215516/
https://www.ncbi.nlm.nih.gov/pubmed/27565435
http://dx.doi.org/10.1080/21645515.2016.1212143

Ejemplares similares